Literature DB >> 26187092

Colorectal Cancer Screening and Race in an Equal Access Medical System.

James D Haddad1, David M You2.   

Abstract

National colorectal cancer (CRC) screening rates have improved, but significant racial disparities have been identified. Improved access to care has been proposed as a solution to eliminate such disparities. To determine if racial disparities in CRC screening rates persist in a medical system without barriers to access or cost. A retrospective review study was performed, examining the healthcare effectiveness data and information set data from patients between the ages of 50 and 65 years who were eligible for CRC screening. Data on the type of CRC screening and rates of up-to-date screening were also examined. Data were available for 14,196 patients of whom 8809 (62%) reported race. Subjects included were 53% male and 47% female, with breakdown by race as follows: 53% White, 34% Asian/Pacific Islander, 11% Black, 1% Hispanic, and <1% Native-American. Overall, CRC screening and up-to-date rates were higher than the national average (81 and 72%, respectively). Blacks were less likely than non-Blacks to have undergone CRC screening (75 vs. 82%, p < 0.001), and were also less likely to be up-to-date with CRC screening (66 vs. 72%, p < 0.001). Despite elimination of access and cost barriers, racial disparities in CRC screening persist. Equal access to CRC screening tools will be necessary, but not sufficient, to eliminate the currently observed national trends. Further study should focus on elucidating patient-specific barriers to successful completion and maintenance of CRC screening.

Entities:  

Keywords:  Access to care; Cancer prevention; Colonoscopy; Colorectal cancer screening; Race; Racial disparities

Mesh:

Year:  2016        PMID: 26187092     DOI: 10.1007/s10900-015-0068-3

Source DB:  PubMed          Journal:  J Community Health        ISSN: 0094-5145


  4 in total

1.  Low uptake of colorectal cancer screening among African Americans in an integrated Veterans Affairs health care network.

Authors:  Folasade P May; Erica G Bromley; Mark W Reid; Michael Baek; Jessica Yoon; Erica Cohen; Aaron Lee; Martijn G H van Oijen; Brennan M R Spiegel
Journal:  Gastrointest Endosc       Date:  2014-03-25       Impact factor: 9.427

2.  Colonoscopic polypectomy and long-term prevention of colorectal-cancer deaths.

Authors:  Ann G Zauber; Sidney J Winawer; Michael J O'Brien; Iris Lansdorp-Vogelaar; Marjolein van Ballegooijen; Benjamin F Hankey; Weiji Shi; John H Bond; Melvin Schapiro; Joel F Panish; Edward T Stewart; Jerome D Waye
Journal:  N Engl J Med       Date:  2012-02-23       Impact factor: 91.245

3.  Emerging and widening colorectal carcinoma disparities between Blacks and Whites in the United States (1975-2002).

Authors:  Kimberly Irby; William F Anderson; Donald E Henson; Susan S Devesa
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2006-04       Impact factor: 4.254

4.  Reducing mortality from colorectal cancer by screening for fecal occult blood. Minnesota Colon Cancer Control Study.

Authors:  J S Mandel; J H Bond; T R Church; D C Snover; G M Bradley; L M Schuman; F Ederer
Journal:  N Engl J Med       Date:  1993-05-13       Impact factor: 91.245

  4 in total
  3 in total

1.  Prostate and Colorectal Cancer Screening Uptake among US and Foreign-Born Males: Evidence from the 2015 NHIS Survey.

Authors:  Daudet Ilunga Tshiswaka; Tiffany Donley; Anthony Okafor; Peter Memiah; Justice Mbizo
Journal:  J Community Health       Date:  2017-06

2.  The intersection of sexual orientation with race and ethnicity in cervical cancer screening.

Authors:  Ashley E Stenzel; Gabriela Bustamante; Courtney A Sarkin; Katherine Harripersaud; Patricia Jewett; Deanna Teoh; Rachel I Vogel
Journal:  Cancer       Date:  2022-05-16       Impact factor: 6.921

Review 3.  A narrative review of sociodemographic risk and disparities in screening, diagnosis, treatment, and outcomes of the most common extrathoracic malignancies in the United States.

Authors:  Sarah Singh; Praveen Sridhar
Journal:  J Thorac Dis       Date:  2021-06       Impact factor: 2.895

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.